Biomedical scientist Mehar Manku will take over as editor-in-chief at Elsevier's embattled, previously non-peer-reviewed journal Medical Hypotheses, the publisher announced today (June 24).
In his new role, Manku, a member of the editorial board since 2004, vows to maintain the journal's unusual aim of distributing novel, radical ideas in medicine and related biomedical sciences while employing a more traditional peer review process than the journal saw under its previous editor, linkurl:Bruce Charlton,;http://www.buckingham.ac.uk/publicity/dofe/charlton.html whose contract was terminated after he refused to implement such a system. "First, we will retain the ethos, heritage and unique characteristics of the journal as they were proposed at inception," Manku said in a statement. "Second, we will engage a medically qualified editorial board to get members more involved in the review system to help ensure radical new ideas and speculations in medicine are given open-minded consideration while ensuring scientific merit." He may have...
 |
The ScientistMedical HypothesesProstaglandins, Leukotrienes and Essential Fatty Acids
Interested in reading more?
Become a Member of
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
